Abstract

Transcription-blocking DNA lesions are removed by transcription-coupled nucleotide excision repair (TC-NER) to preserve cell viability. TC-NER is triggered by the stalling of RNA polymerase II at DNA lesions, leading to the recruitment of TC-NER-specific factors such as the CSA–DDB1–CUL4A–RBX1 cullin–RING ubiquitin ligase complex (CRLCSA). Despite its vital role in TC-NER, little is known about the regulation of the CRLCSA complex during TC-NER. Using conventional and cross-linking immunoprecipitations coupled to mass spectrometry, we uncover a stable interaction between CSA and the TRiC chaperonin. TRiC’s binding to CSA ensures its stability and DDB1-dependent assembly into the CRLCSA complex. Consequently, loss of TRiC leads to mislocalization and depletion of CSA, as well as impaired transcription recovery following UV damage, suggesting defects in TC-NER. Furthermore, Cockayne syndrome (CS)-causing mutations in CSA lead to increased TRiC binding and a failure to compose the CRLCSA complex. Thus, we uncover CSA as a TRiC substrate and reveal that TRiC regulates CSA-dependent TC-NER and the development of CS.

Details

Title
TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A
Author
Pines, Alex 1 ; Dijk, Madelon 2 ; Makowski, Matthew 3 ; Meulenbroek, Elisabeth M 4 ; Vrouwe, Mischa G 2 ; Yana van der Weegen 2   VIAFID ORCID Logo  ; Baltissen, Marijke 3 ; French, Pim J 5 ; van Royen, Martin E 6   VIAFID ORCID Logo  ; Luijsterburg, Martijn S 2 ; Mullenders, Leon H 2 ; Vermeulen, Michiel 3   VIAFID ORCID Logo  ; Vermeulen, Wim 7 ; Pannu, Navraj S 4 ; Haico van Attikum 2 

 Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands; Department of Molecular Genetics, Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, The Netherlands 
 Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands 
 Department of Molecular Biology, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, The Netherlands 
 Department of Biophysical Structural Chemistry, Gorlaeus Laboratories, Leiden University, Leiden, The Netherlands 
 Department of Neurology, Cancer Treatment Screening Facility (CTSF), Erasmus University Medical Center, Rotterdam, The Netherlands 
 Department of Pathology, Cancer Treatment Screening Facility (CTSF), Erasmus Optical Imaging Centre (OIC), Erasmus University Medical Center, Rotterdam, The Netherlands 
 Department of Molecular Genetics, Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam, The Netherlands 
Pages
1-14
Publication year
2018
Publication date
Mar 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2013136344
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.